ME Therapeutics Holdings Inc. (CSE:METX)
Canada flag Canada · Delayed Price · Currency is CAD
10.50
0.00 (0.00%)
Mar 28, 2025, 4:00 PM EST

ME Therapeutics Holdings Statistics

Total Valuation

CSE:METX has a market cap or net worth of CAD 196.42 million. The enterprise value is 195.21 million.

Market Cap 196.42M
Enterprise Value 195.21M

Important Dates

The last earnings date was Friday, March 21, 2025.

Earnings Date Mar 21, 2025
Ex-Dividend Date n/a

Share Statistics

CSE:METX has 26.19 million shares outstanding. The number of shares has increased by 27.71% in one year.

Current Share Class n/a
Shares Outstanding 26.19M
Shares Change (YoY) +27.71%
Shares Change (QoQ) -0.02%
Owned by Insiders (%) 64.02%
Owned by Institutions (%) n/a
Float 9.35M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio 142.37
P/TBV Ratio 148.02
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -155.81
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -357.08

Financial Position

The company has a current ratio of 8.18, with a Debt / Equity ratio of 0.08.

Current Ratio 8.18
Quick Ratio 7.70
Debt / Equity 0.08
Debt / EBITDA n/a
Debt / FCF -0.20
Interest Coverage -472.52

Financial Efficiency

Return on equity (ROE) is -145.75% and return on invested capital (ROIC) is -87.97%.

Return on Equity (ROE) -145.75%
Return on Assets (ROA) -81.00%
Return on Invested Capital (ROIC) -87.97%
Return on Capital Employed (ROCE) -95.06%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +207.92% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +207.92%
50-Day Moving Average 8.38
200-Day Moving Average 5.10
Relative Strength Index (RSI) 35.69
Average Volume (20 Days) 231

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -1.32M
Pretax Income -1.25M
Net Income -1.25M
EBITDA -1.31M
EBIT -1.32M
Earnings Per Share (EPS) -0.05
Full Income Statement

Balance Sheet

The company has 1.33 million in cash and 110,739 in debt, giving a net cash position of 1.22 million or 0.05 per share.

Cash & Cash Equivalents 1.33M
Total Debt 110,739
Net Cash 1.22M
Net Cash Per Share 0.05
Equity (Book Value) 1.33M
Book Value Per Share 0.05
Working Capital 1.26M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -537,834 and capital expenditures -8,834, giving a free cash flow of -546,668.

Operating Cash Flow -537,834
Capital Expenditures -8,834
Free Cash Flow -546,668
FCF Per Share -0.02
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CSE:METX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -27.71%
Shareholder Yield -27.71%
Earnings Yield -0.64%
FCF Yield -0.28%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a